Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Oncotarget
|
February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Caroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget
|
July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Caroline M Robb, Smit Kour, Jacob I Contreras, et al.
Journal of Medicinal Chemistry
|
June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response
Revital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Oncotarget
|
February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Caroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget
|
July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Caroline M Robb, Smit Kour, Jacob I Contreras, et al.
Journal of Medicinal Chemistry
|
June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response
Revital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Page
of 2